Similarly, Maitituoheti et al. [33] showed that Kmt2d loss promoted melanoma in a GEMM and that KMT2D downregulated expression of glycolytic genes by increasing expression of IGFBP5, a tumor suppressor and negative regulator of IGF1R signaling. This evidence concerns the gene KMT2D and neoplasm.